Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Research

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-13-0013PMID 23955388PMCID PMC3773499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disclosure of Potential Conflicts of Interest

  2014cited by this paper
• LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients

  2012cited by this paper
• Cdk2 is required for breast cancer mediated by the low-molecular-weight isoform of cyclin E.

  2011cited by this paper
• A Small-Molecule Inhibitor of Enterocytic Microsomal Triglyceride Transfer Protein, SLx-4090: Biochemical, Pharmacodynamic, Pharmacokinetic, and Safety Profile

  2011cited by this paper
• Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1

  2010cited by this paper
• Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers.

  2009cited by this paper
• Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation.

  2009cited by this paper
• Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes

  2009cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Role for Plk1 phosphorylation of Hbo1 in regulation of replication licensing

  2008cited by this paper
• The CD44+/CD24- phenotype is enriched in basal-like breast tumors

  2008cited by this paper
• Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man?

  2007cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.

  2007cited by this paper
• Histone acetyltransferase HBO1 inhibits NF-kappaB activity by coactivator sequestration.

  2006cited by this paper
• Ligand-controlled interaction of histone acetyltransferase binding to ORC-1 (HBO1) with the N-terminal transactivating domain of progesterone receptor induces steroid receptor coactivator 1-dependent coactivation of transcription.

  2006cited by this paper
• ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.

  2006cited by this paper
• The Tumor-specific Hyperactive Forms of Cyclin E Are Resistant to Inhibition by p21 and p27*

  2005cited by this paper
• Doxorubicin-induced myocardial injury.

  2004cited by this paper
• Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma

  2004cited by this paper
• In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

  2003cited by this paper
• The Low Molecular Weight Isoforms of Cyclin E Deregulate the Cell Cycle of Mammary Epithelial Cells

  2003cited by this paper
• Stem cells in normal breast development and breast cancer

  2003cited by this paper
• Cyclin E and survival in patients with breast cancer.

  2002cited by this paper
• Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms

  2001cited by this paper
• Replication Factors MCM2 and ORC1 Interact with the Histone Acetyltransferase HBO1*

  2001cited by this paper
• Novel splice variants of cyclin E with altered substrate specificity.

  2000cited by this paper
• Doxorubicin-Induced Cardiomyopathy

  2000cited by this paper
• Androgen Receptor Interacts with a Novel MYST Protein, HBO1*

  2000cited by this paper
• Processing of cyclin E differs between normal and tumor breast cells.

  2000cited by this paper
• Doxorubicin-induced cardiomyopathy.

  1998cited by this paper
• Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications.

  1998cited by this paper
• Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions

  1997cited by this paper
• The role of cyclin E in cell proliferation, development and cancer.

  1997cited by this paper
• Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.

  1996cited by this paper
• Deregulation of cyclin E in breast cancer.

  1995cited by this paper
• Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer.

  1995cited by this paper
• Mammalian G1 cyclins.

  1994cited by this paper
• Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle

  1992cited by this paper
• Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

  1992cited by this paper

• Histone acetyltransferase HBO1 in cancer biology: Essential mechanisms and implications for targeted therapeutics.

  2026cites this paper
• A KAT7-lncPVT1 positive feedback loop promotes lung cancer carcinogenesis and therapy resistance via H3K14ac/HDGF/PI3K/AKT Axis.

  2025cites this paper
• Competitive antagonism of KAT7 crotonylation against acetylation affects procentriole formation and colorectal tumorigenesis

  2025cites this paper
• A global phosphosite-correlated network map of Thousand And One Kinase 1 (TAOK1).

  2024cites this paper
• Histone acetyltransferases as promising therapeutic targets in glioblastoma resistance.

  2024cites this paper
• Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.

  2023cites this paper
• Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets

  2023cites this paper
• KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer

  2023cites this paper
• Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer

  2022cites this paper
• Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond

  2022cites this paper
• KAT7 promoted gastric cancer progression through promoting YAP1 activation.

  2022cites this paper
• The phosphorylation to acetylation/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA/histone-modifying enzymes

  2022cites this paper
• Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells

  2022cites this paper
• Role of histone acetyltransferase inhibitors in cancer therapy.

  2021cites this paper
• Protein lysine acetylation and its role in different human pathologies: a proteomic approach

  2021cites this paper
• Oncogenic RAS Generates Cancer Stem Cells in p53-Deficient Fibroblasts Through SOX2 Induced By CDK1-Mediated Protein O-GlcNAcylation

  2021cites this paper
• Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer

  2021cites this paper
• Protein kinase D1 phosphorylation of KAT7 enhances its protein stability and promotes replication licensing and cell proliferation

  2020cites this paper
• The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.

  2019cites this paper
• HBO1 directs histone H4 specific acetylation, potentiating mechano-transduction pathways and membrane elasticity in ovarian cancer cells.

  2019cites this paper
• Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

  2019cites this paper
• Histone Acetyltransferases: Targets and Inhibitors

  2019cites this paper
• Deciphering structure, function and mechanism of lysine acetyltransferase HBO1 in protein acetylation, transcription regulation, DNA replication and its oncogenic properties in cancer

  2019cites this paper
• The scaffolding protein JADE1 physically links the acetyltransferase subunit HBO1 with its histone H3–H4 substrate

  2018cites this paper
• Transcriptional Regulation of the Warburg Effect in Cancer by SIX1.

  2018cites this paper
• Dissecting the Molecular Basis of the Scaffold Protein JADE in HBO1 Histone Acetyltransferase (HAT) Activity

  2018cites this paper
• Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer

  2018cites this paper
• Transcriptional Regulation of the Warburg Effect in Cancer by SIX 1 Graphical Abstract Highlights

  2018cites this paper
• Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

  2018cites this paper
• HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β‐catenin signaling

  2018cites this paper
• LPS promotes HBO1 stability via USP25 to modulate inflammatory gene transcription in THP-1 cells.

  2018cites this paper
• Cytoplasmic Cyclin E is an Early Event for Progression to Invasive Breast Cancer

  2017cites this paper
• RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.

  2017cites this paper
• Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer

  2017cites this paper
• TARGETING AUTOPHAGY TO IMPROVE EFFICACY OF CDK4/6 INHIBITION IN BREAST CANCER

  2017cites this paper
• Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer

  2017cites this paper
• HBO 1 promotes cell proliferation in bladder cancer via activation of Wnt / β-catenin signaling † Running title : HBO 1 promotes bladder cancer proliferation

  2017cites this paper
• Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.

  2016cites this paper
• Targeting the Cell Cycle in Breast Cancer

  2016cites this paper
• Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

  2016cites this paper
• Therapeutic Implications of Epigenetic Signaling in Breast Cancer

  2016cites this paper
• Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

  2016cites this paper
• Molecular cloning and functional characterization of cyclin E and CDK2 from Penaeus monodon.

  2016cites this paper
• Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics.

  2016cites this paper
• Molecular cloning and functional characterization of cyclin E and CDK 2 from Penaeus monodon

  2016cites this paper
• Molecular and clinical dissection of infant acute lymphoblastic leukemia

  2016cites this paper
• Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia

  2015cites this paper
• PKC iota promotes ovarian tumor progression through deregulation of cyclin E

  2015cites this paper
• Regulators of carcinogenesis: emerging roles beyond their primary functions.

  2015cites this paper
• Chapter 21 – Emerging Epigenetic Therapies: Lysine Acetyltransferase Inhibitors

  2015cites this paper
• Emerging Epigenetic Therapies

  2015cites this paper
• Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.

  2015cites this paper
• New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

  2014cites this paper
• KATs in Cancer: Functions and Therapies

  2014cites this paper
• Cytoplasmic Cyclin E and Phospho e Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer

  year unknowncites this paper
• ERR α confers oncogenesis and cisplatin resistance via transcriptionally activating CCNE2 in breast cancer

  year unknowncites this paper
• of radioresistance in glioblastoma stem-like

  year unknowncites this paper